Understanding how certain proteins affect gene regulation in cancer and neurodegenerative diseases
Liquid-Liquid Phase Separation in Heterochromatin Organization
['FUNDING_R01'] · TEXAS ENGINEERING EXPERIMENT STATION · NIH-10656526
This study is looking at how a special kind of DNA packaging affects gene activity, which could help us understand cancer and diseases like ALS and FTD, so we can find better ways to help patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS ENGINEERING EXPERIMENT STATION (nih funded) |
| Locations | 1 site (COLLEGE STATION, UNITED STATES) |
| Trial ID | NIH-10656526 on ClinicalTrials.gov |
What this research studies
This research investigates the role of heterochromatin, a type of DNA packaging, in regulating gene expression and its implications for cancer and neurodegenerative diseases like ALS and FTD. By studying how specific proteins interact and form liquid-like droplets, the research aims to uncover the mechanisms that lead to improper gene regulation. The approach combines computational modeling with experimental techniques to provide insights into the molecular processes involved. Patients may benefit from a better understanding of how these mechanisms contribute to their conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals diagnosed with various forms of cancer or neurodegenerative diseases such as ALS and FTD.
Not a fit: Patients with conditions unrelated to gene regulation or those not diagnosed with cancer or neurodegenerative diseases may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating cancers and neurodegenerative diseases.
How similar studies have performed: Previous research has shown promising results in understanding gene regulation through similar molecular mechanisms, indicating potential for success in this area.
Where this research is happening
COLLEGE STATION, UNITED STATES
- TEXAS ENGINEERING EXPERIMENT STATION — COLLEGE STATION, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MITTAL, JEETAIN — TEXAS ENGINEERING EXPERIMENT STATION
- Study coordinator: MITTAL, JEETAIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer